AAAAAA

   
Results: 1-12 |
Results: 12
Quality of life and disability in patients with obsessive-compulsive disorder
Authors: Bobes, J Gonzalez, MP Bascaran, MT Arango, C Saiz, PA Bousono, M
Citation: J. Bobes et al., Quality of life and disability in patients with obsessive-compulsive disorder, EUR PSYCHIA, 16(4), 2001, pp. 239-245
Sexual dysfunction in depressed patients undergoing treatment with antidepressants
Authors: Merino, MJ Gonzalez, P Muniz, J Bobes, J
Citation: Mj. Merino et al., Sexual dysfunction in depressed patients undergoing treatment with antidepressants, INT J PSYC, 4(4), 2000, pp. 311-317
Schizophrenia: diagnosis and continuing treatment - principles of practicefrom the European expert panel on the contemporary treatment of schizophrenia
Authors: Altamura, AC Bobes, J Owens, DC Gerlach, J Hellewell, JSE Kasper, S Naber, D Tarrier, N Van Os, J
Citation: Ac. Altamura et al., Schizophrenia: diagnosis and continuing treatment - principles of practicefrom the European expert panel on the contemporary treatment of schizophrenia, INT J PSYC, 4, 2000, pp. S1-S11
The importance of psychosocial interventions and patient involvement in the treatment of schizophrenia
Authors: Tarrier, N Bobes, J
Citation: N. Tarrier et J. Bobes, The importance of psychosocial interventions and patient involvement in the treatment of schizophrenia, INT J PSYC, 4, 2000, pp. S35-S51
Therapeutic advances: Paroxetine for the treatment of social anxiety disorder
Authors: Lydiard, RB Bobes, J
Citation: Rb. Lydiard et J. Bobes, Therapeutic advances: Paroxetine for the treatment of social anxiety disorder, DEPRESS ANX, 11(3), 2000, pp. 99-104
Developments in the treatment of drug dependence
Authors: Bobes, J McCann, UD
Citation: J. Bobes et Ud. Mccann, Developments in the treatment of drug dependence, CUR OPIN P, 13(3), 2000, pp. 333-338
A European perspective on social anxiety disorder
Authors: Lecrubier, Y Wittchen, HU Faravelli, C Bobes, J Patel, A Knapp, M
Citation: Y. Lecrubier et al., A European perspective on social anxiety disorder, EUR PSYCHIA, 15(1), 2000, pp. 5-16
Interpretation of health-related quality of life (HRQOL) results of patients on renal replacement therapy (RRT)
Authors: Rebollo, P Gonzalez, MP Bobes, J Saiz, P Ortega, F
Citation: P. Rebollo et al., Interpretation of health-related quality of life (HRQOL) results of patients on renal replacement therapy (RRT), NEFROLOGIA, 20(5), 2000, pp. 431-439
Variables which influence the health related quality of life (HRQOL) of patients on renal replacement therapy (RRT)
Authors: Rebollo, P Bobes, J Gonzalez, MP Saiz, P Ortega, F
Citation: P. Rebollo et al., Variables which influence the health related quality of life (HRQOL) of patients on renal replacement therapy (RRT), NEFROLOGIA, 20(2), 2000, pp. 171-181
Validation of the Spanish version of the Changes in Sexual Functioning Questionnaire (CSFQ)
Authors: Bobes, J Gonzalez, MP Rico-Villandemoros, F Bascaran, MT Sarasa, P Clayton, A
Citation: J. Bobes et al., Validation of the Spanish version of the Changes in Sexual Functioning Questionnaire (CSFQ), J SEX MAR T, 26(2), 2000, pp. 119-131
Validation of the Spanish versions of the Liebowitz Social Anxiety Scale, Social Anxiety and Distress Scale and Sheehan Disability Inventory for the evaluation of social phobia
Authors: Bobes, J Badia, X Luque, A Garcia, M Gonzalez, MP Dal-Re, R
Citation: J. Bobes et al., Validation of the Spanish versions of the Liebowitz Social Anxiety Scale, Social Anxiety and Distress Scale and Sheehan Disability Inventory for the evaluation of social phobia, MED CLIN, 112(14), 1999, pp. 530-538
Paroxetine in social phobia/social anxiety disorder - Randomised, double-blind, placebo-controlled study
Authors: Baldwin, D Bobes, J Stein, DJ Scharwachter, I Faure, M
Citation: D. Baldwin et al., Paroxetine in social phobia/social anxiety disorder - Randomised, double-blind, placebo-controlled study, BR J PSYCHI, 175, 1999, pp. 120-126
Risultati: 1-12 |